Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
主要な著者: | Phillips, A, Walker, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2004
|
類似資料
-
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
著者:: Nicola Gianotti, 等
出版事項: (2017-01-01) -
Timeliness of clinic attendance is a good predictor of virological response and resistance to antiretroviral drugs in HIV-infected patients.
著者:: Mathieu Bastard, 等
出版事項: (2012-01-01) -
Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
著者:: Fidler, S, 等
出版事項: (2002) -
Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
著者:: Fidler, S, 等
出版事項: (2002) -
HIV multi‐drug resistance at first‐line antiretroviral failure and subsequent virological response in Asia
著者:: Awachana Jiamsakul, 等
出版事項: (2014-01-01)